Literature DB >> 9020482

Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.

L Håkansson1, G Adell, B Boeryd, F Sjögren, R Sjödahl.   

Abstract

Local immunoregulation mediated by mononuclear tumour-infiltrating cells is considered of importance for tumour progression of colorectal cancer, although the balance between immunosuppressor and cytotoxic activities is unclear. Colorectal cancers from 26 patients were investigated using a panel of monoclonal antibodies in order to identify subsets of mononuclear inflammatory cells and to study their pattern of distribution in relation to tumour stage and cytotoxic immune reactivity against the tumour. In all but five tumours, mononuclear cells, lymphocytes or monocytes were present in fairly large numbers, particularly in the stroma. The infiltration of CD4+ mononuclear cells predominated over the CD8+ subset. Infiltration near the tumour cells was found in four cancers only. Stromal infiltration of CD11c+ macrophages was found in all but eight tumours. Small regressive areas, in which the histological architecture of the tumours was broken down, were found in 17 tumours with intense or moderate infiltration by CD4+ lymphocytes or CD11c+ macrophages. Probably this destruction of tumour tissue was caused by cytotoxic activity of the tumour-infiltrating mononuclear cells. In Dukes' class A and B tumours, CD4+ lymphocytes predominated over CD4+ cells with macrophage morphology, but the latter were increasingly found in Dukes' class C and D disease. The occurrence of MHC II-positive macrophages and lymphocytes in different Dukes' classes was similar to that of CD4+ cells. In contrast to this, CD11c+ and CD11a+ cells were more frequent in Dukes' A and B class tumours compared with Dukes' C and D. Four out of nine tumours of the latter stages showed a poor inflammatory reaction. The interpretation of our results is that the subsets of tumour-infiltrating mononuclear cells change with advancing Dukes' class and that the local immune control is gradually broken down in progressive tumour growth, even if some cytotoxic activity is still present.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020482      PMCID: PMC2063367          DOI: 10.1038/bjc.1997.61

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.

Authors:  R W Baldwin; M J Embleton; M R Price
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

2.  Separation and characteristics of tumor-infiltrating lymphocytes in man.

Authors:  E Klein; F Vánky; U Galili; B M Vose; M Fopp
Journal:  Contemp Top Immunobiol       Date:  1980

3.  Inhibition of normal allogenic lymphocyte mitogenesis by a soluble inhibitor extracted from human colonic carcinoma.

Authors:  M M Remacle-Bonnet; F J Pommier; S Kaplanski; R J Rance; R C Depieds
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

4.  An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture.

Authors:  J S Whitehead; Y S Kim
Journal:  Cancer Res       Date:  1980-01       Impact factor: 12.701

Review 5.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

6.  Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.

Authors:  S N Andersen; T O Rognum; E Lund; G I Meling; S Hauge
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

7.  Surface markers of cloned human T cells with various cytolytic activities.

Authors:  L Moretta; M C Mingari; P R Sekaly; A Moretta; B Chapuis; J C Cerottini
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

8.  Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells.

Authors:  G H Hutchinson; D Heinemann; M O Symes; R C Williamson
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

9.  The significance of lymphocytic infiltration in neuroblastoma.

Authors:  I Lauder; W Aherne
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

10.  Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma.

Authors:  J A Werkmeister; E Pihl; A P Nind; G R Flannery; R C Nairn
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

View more
  12 in total

1.  Suppression of the reactive oxygen intermediates production of human macrophages by colorectal adenocarcinoma cell lines.

Authors:  A Siegert; C Denkert; A Leclere; S Hauptmann
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients' survival.

Authors:  Maya Gulubova; Julian Ananiev; Yovchev Yovchev; Aleksander Julianov; Anatoli Karashmalakov; Tatyana Vlaykova
Journal:  J Mol Histol       Date:  2013-06-26       Impact factor: 2.611

3.  Proliferation of T-cell subsets that contact tumour cells in colorectal cancer.

Authors:  S J C Golby; C Chinyama; J Spencer
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

4.  High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

Authors:  R Dolcetti; A Viel; C Doglioni; A Russo; M Guidoboni; E Capozzi; N Vecchiato; E Macrì; M Fornasarig; M Boiocchi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

5.  Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7.

Authors:  C A Maxwell-Armstrong; L G Durrant; R A Robins; A M Galvin; J H Scholefield; J D Hardcastle
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

6.  Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer.

Authors:  Joan How; Jason R Brown; Sasha Saylor; David L Rimm
Journal:  Histochem Cell Biol       Date:  2014-01-16       Impact factor: 4.304

7.  Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment.

Authors:  María Florencia Pansa; María Julia Lamberti; Ingrid Sol Cogno; Silvia Graciela Correa; Natalia Belén Rumie Vittar; Viviana Alicia Rivarola
Journal:  Tumour Biol       Date:  2015-08-01

8.  Expression of thymidine phosphorylase by macrophages in colorectal cancer tissues.

Authors:  Ji-Min Zhang; Takayuki Mizoi; Ken-Ichi Shiiba; Iwao Sasaki; Seiki Matsuno
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 9.  Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.

Authors:  Charles Maxwell-Armstrong
Journal:  Ann R Coll Surg Engl       Date:  2002-09       Impact factor: 1.891

10.  Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study.

Authors:  I D Nagtegaal; C A Marijnen; E K Kranenbarg; A Mulder-Stapel; J Hermans; C J van de Velde; J H van Krieken
Journal:  BMC Cancer       Date:  2001-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.